Indications and uses
temporarily relieves minor aches and pains due to: headache muscular aches minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
temporarily relieves minor aches and pains due to: headache muscular aches minor pain of arthritis toothache backache the common cold menstrual cramps temporarily reduces fever
do not take more than directed the smallest effective dose should be used adults and children 12 years and older take 1 caplet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 caplet, 2 caplets may be used do not exceed 6 caplets in 24 hours, unless directed by a doctor children under 12 years ask a doctor
store between 20-25°C (68-77°F) do not use if packet is opened
Drug Facts
Pain reliever/fever reducer
Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin.
Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
This product contains an NSAID, which may cause severe stomach bleeding.
The chance is higher if you:
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
| adults and children 12 years and older |
|
| children under 12 years |
|
carnauba wax, colloidal silicon dioxide, corn starch, FD&C yellow no. 6, hypromellose, iron oxide, magnesium stearate, polydextrose, polyethylene glycol, pregelatinized starch, propylene glycol, shellac, stearic acid, titanium dioxide
Call 1-877-895-3665 (toll-free) or 215-273-8755 (collect)
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-110-01 | EA - Each | 50580-110 | 867365d4-4425-426f-bf59-46f6dfabd14b | 1 | 2012-07-24 |
| 50580-110-02 | EA - Each | 50580-110 | 31401772-7c9b-4d71-a279-1ec4a77f0952 | 1 | 2012-07-24 |
| 50580-110-03 | EA - Each | 50580-110 | 914bf222-d4b9-4d69-bcff-2e30fd34d5f6 | 1 | 2012-07-24 |
| 50580-110-09 | EA - Each | 50580-110 | 1589ab72-c436-43bf-bf25-c883ae326ea2 | 1 | 2012-07-24 |
| 50580-110-19 | EA - Each | 50580-110 | 70e17cab-9b09-4dd3-833f-5acdbedda78b | 1 | 2012-07-24 |
| 50580-110-37 | EA - Each | 50580-110 | 87af4730-f4f3-48ea-a65f-b5c15c0e194c | 1 | 2012-07-24 |
| 50580-110-52 | EA - Each | 50580-110 | 82dfca75-6914-4194-8717-ea1fd3354c1b | 1 | 2012-07-24 |
| 50580-110-60 | EA - Each | 50580-110 | 6ea6daa9-b107-4f42-b767-9b0336899dfd | 1 | 2012-07-24 |
| 50580-110-62 | EA - Each | 50580-110 | 2b192ee9-708a-4776-96db-60c8310b4b84 | 1 | 2012-07-24 |
| 50580-110-64 | EA - Each | 50580-110 | 62c27713-706d-4be9-b73c-34d7ffc20955 | 1 | 2012-07-24 |
| 50580-110-95 | EA - Each | 50580-110 | d939130b-4e12-4684-a078-d07ccdbfba52 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Ibuprofen | ACTIVE INGREDIENT | WK2XYI10QM | 4 | |
| Ibuprofen | ACTIVE MOIETY | WK2XYI10QM | 4 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | 4 | |
| FD&C yellow no. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 4 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | 4 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 4 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 4 | |
| polydextrose | INACTIVE INGREDIENT | VH2XOU12IE | 4 | |
| polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 4 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 4 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | 4 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 4 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | 4 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 4 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50580-110 | 50580-110-01, 50580-110-02, 50580-110-07, 50580-110-09, 50580-110-10, 50580-110-19, 50580-110-38, 50580-110-51, 50580-110-52, 50580-110-60, 50580-110-62, 50580-110-75, 50580-110-76, 50580-110-95 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Ibuprofen | WK2XYI10QM | ACTIB |
| carnauba wax | R12CBM0EIZ | IACT |
| silicon dioxide | ETJ7Z6XBU4 | IACT |
| starch, corn | O8232NY3SJ | IACT |
| FD&C yellow no. 6 | H77VEI93A8 | IACT |
| hypromellose, unspecified | 3NXW29V3WO | IACT |
| ferrosoferric oxide | XM0M87F357 | IACT |
| magnesium stearate | 70097M6I30 | IACT |
| polydextrose | VH2XOU12IE | IACT |
| polyethylene glycol, unspecified | 3WJQ0SDW1A | IACT |
| propylene glycol | 6DC9Q167V3 | IACT |
| shellac | 46N107B71O | IACT |
| stearic acid | 4ELV7Z65AP | IACT |
| titanium dioxide | 15FIX9V2JP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| FD&C yellow no. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| shellac | SHELLAC | 46N107B71O | CAPSULE, COATED PELLETS / ORAL | 29 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | CAPSULE, EXTENDED RELEASE / ORAL | 288 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / SUBLINGUAL | 36 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v | ||
| polydextrose | POLYDEXTROSE | VH2XOU12IE | TABLET, FILM COATED / ORAL | 18 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | JELLY / TOPICAL | 20 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| FD&C yellow no. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, DELAYED RELEASE / ORAL | 2 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 7 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL, METERED / TOPICAL | 1225 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET / SUBLINGUAL | 409 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM / BUCCAL | 3 mg | ||
| ferrosoferric oxide | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| FD&C yellow no. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SOLUTION / ORAL | 75.3 mg/15ml | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO / TOPICAL | 8 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| FD&C yellow no. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | DROPS / ORAL | 0.2 mg/1ml | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, SOLUBLE / BUCCAL | 5 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019012-001 | NUPRIN | IBUPROFEN | 200MG | TABLET / ORAL | 1984-05-18 | ||
| N019012-002 | NUPRIN | IBUPROFEN | 200MG | TABLET / ORAL | 1987-07-29 | ||
| N019012-003 | MOTRIN IB | IBUPROFEN | 200MG | TABLET / ORAL | RLD | 1990-12-17 | |
| N019012-004 | MOTRIN MIGRAINE PAIN | IBUPROFEN | 200MG | TABLET / ORAL | 2000-02-25 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019012-001 | NUPRIN | 200MG | TABLET / ORAL | 1984-05-18 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019012-002 | NUPRIN | 200MG | TABLET / ORAL | 1987-07-29 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019012-003 | MOTRIN IB | 200MG | TABLET / ORAL | RLD | 1990-12-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019012-004 | MOTRIN MIGRAINE PAIN | 200MG | TABLET / ORAL | 2000-02-25 | 03ed91905a0d… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7acc81be-5284-41de-b5d0-626c7fa74ce2 | 5bca517f-94a5-428c-b716-80c6b0b86980 | 2020-04-24 | Warnings | 5bca517f-94a5-428c-b716-80c6b0b86980 |
Adverse event summaries are temporarily unavailable. Other product information remains available.